Honda Motor Co. (TYO:7267) and Nissan Motor Co. (TYO:7201) shares surged on Wednesday after reports suggested they may abandon merger plans. Honda's stock rose 2.9%, while Nissan gained 4.3%. Toyota Motor Corp. (TYO:7203) also climbed 1.7%, with the Nikkei 225 index increasing by 0.3%.
According to Japan’s Asahi Shimbun, Honda and Nissan's boards will soon discuss terminating merger talks. Honda reportedly proposed making Nissan its subsidiary, a move strongly opposed by Nissan executives. The two companies had initially announced merger discussions last year, aiming to create the world’s third-largest automaker, trailing only Volkswagen (ETR:VOWG_p) and Toyota (NYSE:TM).
The potential cancellation could be a significant setback for Nissan, Japan’s third-largest automaker, which is struggling amid a global shift to electric vehicles, particularly in China. The company has been working to regain market share but faces strong competition from EV leaders like Tesla and BYD.
Japanese automakers are also navigating uncertainty over U.S. trade policies. President Donald Trump recently postponed a proposed 25% tariff on Mexico, a crucial manufacturing hub, by 30 days.
If the merger falls through, Honda and Nissan will need to reassess their strategies to stay competitive in an evolving global auto market.


OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints
SK Hynix Shares Fall as Workers Reject Wage Deal
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Toyota Global Sales Fall as China Demand Slumps
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Trump Buys SpaceX Shares After Record IPO
New Zealand Moves to Ban Social Media for Children Under 16
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 



